ISRCTN99353996进行中（未招募）Unknown
A multicenter, prospective, randomized controlled trial of surgical versus conservative treatment in patients with temporomandibular joint anterior displacement without reduction
West China Medical Center of Sichuan University0 个研究点目标入组 90 人开始时间: 2024年3月6日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients with temporomandibular joint anterior disc displacement without reduction (ADDWoR) who have not previously been treated
- •2. Available and well-preserved clinical data
- •3. Adults aged 18 to 55 years old
排除标准
- •1. Presence of biased chewing habits or significant occlusal interference
- •2. Presence of other severe illnesses or organ dysfunction
- •3. Incomplete clinical data
- •4. Individuals under the age of 18 years
研究者
相似试验
招募中
4 期
A multi center, prospective, randomized controlled trial comparing cervical arthroplasty to anterior cervical discectomy and fusion (ACDF) for the treatment of cervical degenerative disc disease.Cervical disc disease10019190NL-OMON39490Johnson & Johnson50
招募中
4 期
A multi-center, prospective, randomised controlled trial comparing the efficacy and safety of PRODISC-C implant to anterior cervical discectomy and fusion (ACDF) surgery, in the treatment of symptomatic cervical disc disease (SCDD)Symptomatic cervical disc disease (SCDD)Musculoskeletal - Other muscular and skeletal disordersACTRN12611000646943Synthes Asia Pacific300
进行中（未招募）
1 期
Influence of Inhaled Aviptadil on Cough and Quality of life in SarcoidosisEUCTR2017-004219-37-DEniversitätsklinikum Freiburg, Leitender Ärztlicher Direktor200
尚未招募
4 期
A prospective, multicenter, randomized, controlled study to evaluate the clinical outcome of Zhenyuan capsule in the treatment of heart failure after myocardial infarctioHeart failure after myocardial infarctionITMCTR2200005706Zhongshan Hospital affiliated to Fudan University
进行中（未招募）
不适用
A multicenter, randomized, prospective, controlled study to evaluate the efficacy and the tolerability of a switch to a two different-dosed, nevirapine-based HAARTs in HIV-1 infected patients with undetectable plasma viremia. - SNODOEUCTR2006-002582-39-ITFONDAZIONE NADIR ONLUS200